The immune responses elicited by the injured liver in NASH are also controlled by miRNAs through the implication of several signaling pathways including transforming growth factor beta (TGF-β1)-signaling, cytokine-signaling, and toll-like receptors (TLRs) signaling [36,40]. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.